chr17-5033015-G-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_017986.4(SLC52A1):āc.1289C>Gā(p.Thr430Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017986.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC52A1 | NM_017986.4 | c.1289C>G | p.Thr430Ser | missense_variant | 5/5 | ENST00000254853.10 | NP_060456.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC52A1 | ENST00000254853.10 | c.1289C>G | p.Thr430Ser | missense_variant | 5/5 | 1 | NM_017986.4 | ENSP00000254853.5 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152182Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250242Hom.: 0 AF XY: 0.0000665 AC XY: 9AN XY: 135252
GnomAD4 exome AF: 0.0000233 AC: 34AN: 1461526Hom.: 0 Cov.: 30 AF XY: 0.0000344 AC XY: 25AN XY: 727040
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152300Hom.: 0 Cov.: 31 AF XY: 0.0000537 AC XY: 4AN XY: 74472
ClinVar
Submissions by phenotype
Ariboflavinosis Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 18, 2021 | Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with SLC52A1-related conditions. This variant is present in population databases (rs568958678, gnomAD 0.05%). This sequence change replaces threonine, which is neutral and polar, with serine, which is neutral and polar, at codon 430 of the SLC52A1 protein (p.Thr430Ser). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at